Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
09:32 ET | 687 | 2.787 |
09:36 ET | 774 | 2.655 |
09:52 ET | 7030 | 2.6 |
09:57 ET | 100 | 2.6327 |
10:01 ET | 809 | 2.66 |
10:06 ET | 1000 | 2.5611 |
10:08 ET | 1542 | 2.61 |
10:10 ET | 100 | 2.61 |
10:15 ET | 3000 | 2.5802 |
10:32 ET | 600 | 2.65 |
10:35 ET | 209 | 2.694 |
10:37 ET | 100 | 2.658 |
11:02 ET | 1700 | 2.5998 |
11:06 ET | 109 | 2.64 |
11:11 ET | 1135 | 2.67 |
11:31 ET | 370 | 2.6508 |
12:02 ET | 404 | 2.64 |
12:05 ET | 150 | 2.62 |
12:27 ET | 300 | 2.65 |
12:56 ET | 4679 | 2.6 |
01:30 ET | 200 | 2.65 |
01:37 ET | 200 | 2.6 |
01:39 ET | 800 | 2.62 |
02:09 ET | 100 | 2.6 |
02:24 ET | 5000 | 2.6048 |
02:27 ET | 100 | 2.6 |
03:00 ET | 100 | 2.64 |
03:03 ET | 100 | 2.63 |
03:30 ET | 1000 | 2.64 |
03:39 ET | 3602 | 2.63 |
03:57 ET | 1898 | 2.62 |
03:59 ET | 548 | 2.64 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 69.4M | -2.5x | --- |
Atara Biotherapeutics Inc | 75.1M | -0.3x | --- |
Cue Biopharma Inc | 79.0M | -1.5x | --- |
Affimed NV | 63.8M | -0.5x | --- |
Kezar Life Sciences Inc | 51.3M | -0.5x | --- |
Ikena Oncology Inc | 64.2M | -0.8x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $69.4M |
---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | 5.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.